Abstract. There is a limited number of reports regarding detergents and proteases inactivating, degrading, or destabilizing abnormal prion protein (PrP Sc ). In the present study, the effect of alkaline detergents and proteases on the breakdown of PrP Sc in the absence of proteinase K (PK) (degradation) and the presence of PK (destabilization) was investigated. PrP
Introduction
Prion is an infectious pathogen causing prion diseases such as bovine spongiform encephalopathy in cattle, CreutzfeldtJakob Disease (CJD) in humans, and scrapie in sheep (1) . Prion is mainly composed of abnormal prion protein (PrP Sc ) that is converted from cellular prion protein (PrP C ) (2) . As PrP C is highly expressed in neurons (3, 4) , the amyloids are easily formed in neuron and thus, neuronal cell loss, the accumulation of PrP Sc , and astrogliosis are all hallmarks of prion diseases (5) . CJD, as well as some inherited prion diseases in Gerstmann-Sträussler-Scheinker syndrome and fatal familial insomnia, is transmissible among humans (2) . Therefore, the inactivation of prion on surgical tools and medical instruments which are re-used is an important concern for public health.
There are four known types of CJD, namely: sporadic CJD, familial CJD, iatrogenic CJD and variant CJD (6) . About 90% of CJD cases are classified as sporadic, with no family history and no known source of transmission, and this form has an incidence rate of 1/million. The second most common form is familial CJD which is inherited (less than 10%). Less than 1% of CJD cases are thought to be iatrogenic or variant in nature (7) . The ratio of iatrogenic CJD, which occurs through infection as a result of medical activities, is relatively small but has become somewhat of a problem in healthcare settings (8) . The reason for this is that most of the sterilization processes that have been used up to now including autoclaving for 15 min at 121˚C, dry heat sterilization for 2 h at 180˚C, and treatment with glutaraldehyde and peracetic acid cannot inactivate PrP Sc and thus, there is a risk of infection through medical and dental instruments (9) . Up to now, it has been reported that more than 350 people have been infected through the implantation of cornea transplants, growth hormone and blood transfusions, and electrodes that come into direct contact with the brain (10, 11) .
The World Health Organization recommends methods such as autoclaving for 18 min at 134˚C, and immersion or boiling in strong denaturants or alkali as countermeasures to prevent CJD infection (12) . However, these methods may damage or destroy medical instruments, especially fragile and expensive items such as gastroscopes for which mild sterilization is preferable (13) and thus, a PrP Sc decontamination method that is effective, can be routinely applied in healthcare settings, and is compatible with that required by humans and the environment (14) .
To assess the effect of treatment on PrP Sc , Lemmer et al defined three categories; 'degradation', 'detachment' and 'destabilization' (15) . Degradation indicates that after treating PrP Sc with a reagent, even without proteinase K (PK) digestion, the signal from a Western blot analysis can either only be detected in a significantly reduced amount or not be detected at all. On the other hand, destabilization indicates that the signal can be detected without PK digestion, but can either only be detected in a significantly reduced amount or not be detected at all upon PK digestion. In this report, we investigated the degradative and destabilizing effects of alkaline detergents and proteases shown in Table I on PrP Sc .
Materials and methods
Detergents and proteases. Yogore Toreiru R (YT; Saraya Co., Ltd., Osaka, Japan) and Power Quick W (PQ; Saraya Co., Ltd.) were used as the alkaline detergents. The former contains 1% surfactants, has 5.6% free alkali and is often used as a detergent for floor maintenance purposes, while the latter has 11.4% free alkali and is used as a detergent dedicated for washer disinfectors (automated reprocessing machines). With respect to PQ, because it is a surfactant-free formulation, an oligolipid type of biosurfactant called sophorolipid (SL; Saraya Co., Ltd.) was added to PQ at concentrations of 0.3% (w/w) and 1% (w/w) and utilized as additional test samples (namely: PQ+0.3% SL and PQ+1% SL). Savinase Ultra 16XL (Savinase; Novozymes Japan Co., Ltd., Chiba, Japan) and Esperase 8.0L (Esperase; Novozymes Japan Co., Ltd.) were used as the protease for testing. For comparison, a product proven to be effective in inactivating PrP Sc , namely: Hamo™ 100 Prion Inactivating Detergent (Hamo 100; Steris Co., Ltd., Ohio, USA), and a product proven to have a destabilizing effect on PrP Sc , namely: 28 deconex Alkaone (Alkaone; Borer Chemie AG Co., Ltd., Zuchwil, Switzerland), were used. Products used in this study are summarized in Tables I   and II . Protex PRP (Protex) was kindly provided by Genencor International (Palo Alto, CA, USA). With respect to all the enzyme reagents tested, test conditions were adjusted to a pH value of 12.0 using sodium hydroxide.
Sample preparation and Western blotting. Brain homogenate of terminally-diseased mice infected with the Chandler strain of scrapie was used to confirm the efficacy against PrP Sc . Brain homogenate (5μl, equivalent to 60 μg of protein) in phosphate-buffered saline (PBS) was added to enough distilled water to adjust the concentration of the test sample to the designated value, such that the total volume was 50 μl. After the destabilization process was performed at the designated test concentration and temperature, the solution was transferred to an ice bath and 22 μl of 1 M phosphate buffer were added. If PK treatment was to be performed, 8 μl of 20 mg/ml PK were added for 1 h at 37˚C. If PK treatment was not to be performed, then 8 μl of PBS buffer instead of PK were added. After 80 μl of 2x loading buffer [150 mM Tris pH 6.8, 6% sodium dodecyl sulfate (SDS), 30% glycerol, 0.03% bromophenol blue] was added and heating (boiling) for 5 min at 100˚C, PrP Sc was detected using SDS-polyacrylamide gel electrophoresis (PAGE) (16) and Western blotting with the anti-PrP antibody SAF83 (SPI bio, Montigny le Bretonneux, France) which recognizes residues 126-164 of PrP (17) .
Results and discussion
First, we examined the effect of alkaline detergents and proteases on the degradation and destabilization of PrP Sc under conditions recommended by the manufacturers (Fig. 1A) : 2%, 60˚C, 30 min, pH 12.0 in Protex, 0.3%, 70˚C, 30 min, pH 11.4 in Alkaone, and 1.6%, 43˚C, 15 min in Hamo 100. A Table I . Alkaline detergents and enzyme reagents. ---------------------------------------------------------------------------------------------------- Table II . Products with an inactivating or destabilizing effect on PrP
Sc . Alkaline detergent Steris Co., Ltd.
1.6%, 43˚C, 15 min -----------------------------------------------------------------------------------------------------
a The concentration of detergent used was determined based on the hardness of water used in the healthcare facility (water quality: soft (<125 ppm), 0.3%; medium hard (125-375 ppm), 0.5%; hard (>375 ppm; 0.7%). In this study, water hardness was 50 ppm and thus, the detergent was used at a concentration of 0.3%.
-----------------------------------------------------------------------------------------------------
comparison suggested Hamo 100 to be more effective against PrP Sc than Alkaone. Protex showed no bands of PrP in the absence or presence of PK on Western blotting of SAF83, suggesting a degradative effect of Protex. On the other hand, Alkaone and Hamo 100 indicated only destabilization because signals were obtained in the absence but not presence of PK.
Second, the detergents and proteases were subjected to an analysis of the degradative and destabilizing effect on PrP Sc under the same conditions (60˚C, 30 min) (Fig. 1B) . The result showed that Protex and Hamo 100 had complete degradative and destabilizing effects, whereas Alkaone had a significant but not complete destabilizing effect and no degradative effect. These results suggest that the incubation conditions are essential for sufficient degradation and destabilization.
Next, the effect of other alkaline detergents on PrP Sc was investigated. YT and PQ had a fully destabilizing effect on PrP Sc similar to Hamo 100 at 1.6%, 43˚C, and 15 min (Fig. 2) . On the other hand, YT and PQ were no less effective than Hamo 100 in terms of the degradation of PrP Sc . Regarding this discrepancy between Hamo 100 and the two detergents (YT and PQ), a high concentration of free alkali in the presence of detergent may contribute to the effectiveness of Hamo 100, because the combination of alkali and detergent is effective against PrP Sc . However, further study will be needed to fully explain the discrepancy. In this study, we also Sc at the same concentration under same conditions. Scrapie-infected brain homogenate (chandler) was incubated in 2% (w/v) Protex, Savinase and Esperase for 30 min at 60˚C and pH 12.0. Un-treated samples (control) were also included. After the incubation, proteins were incubated in the absence (-) and presence (+) of PK at neutral pH (pH 7.0) for 1 h at 37˚C. The samples were further subjected to SDS-PAGE and Western blotting with anti-PrP antibody, SAF83, for PrP Sc or total PrP, respectively. A broad PrP Sc signal with an approximate molecular weight of 15-32 kDa was observed in the control sample but not in other proteasetreated samples. Total PrP showing broad signals with an approximate molecular weight of 20-37 kDa, which was observed in the control sample, was also under the detectable limit in all protease-treated samples. Protein molecular mass markers (kDa) are shown on the left. examined the combined effects of SL and PQ against PrP Sc . The result demonstrated that SL did not enhance the degradation of PrP Sc . Finally, the effect of commercial alkali proteases (Savinase and Esperase) on PrP Sc at 2%, 60˚C, pH 12.0, and 30 min was investigated (Fig. 3) . Interestingly, both Savinase and Esperase degraded and destabilized PrP Sc under the conditions studied. Several alkaline detergents and enzyme reagents have proven effective in inactivating or destabilizing PrP Sc , and are currently available on the market. The subtilisin-enzyme Properase is reported to be able to degrade PrP Sc at high temperatures under alkaline conditions (18) , while a keratinase from Bacillus licheniformis requires >100˚C and the presence of a detergent to break down PrP Sc (19) . An alkaline protease, E77, derived from Streptmyces species has shown degradation of PrP Sc at 60˚C and pH 11.0 (20) . Hamo 100 and Properase were proved to eliminate prion infectivity (18, 21 ). An alkaline detergent, high pH and high temperature may destabilize the rigid structure of PrP Sc , and are expected not only to remove PrP Sc from medical instruments, but also to prevent its reattachment (21) .
Moreover, although some studies have shown that digestion with a protease in the presence of denaturing agents is sufficient to eliminate the infectivity of prion (22) , others suggested a difference between the removal of immunoreactive material and infectivity (23) (24) (25) (26) (27) . Alternatively, residual infectivity may be found in the portion of PrP Sc not recognized by SAF83. Therefore, a mouse bioassay of infectivity would be needed to test the effectiveness of these commercial alkaline detergents and proteases.
Taken together, the results of this study demonstrate the usefulness of commercial alkaline detergents and proteases for the degradation or destabilization of PrP Sc , and suggest that their effectiveness against prion can be increased.
